ARTICLE SUMMARY:
Edwards Lifesciences execs discuss regulatory and reimbursement strategies for their pioneering tricuspid valve, one of CMS' test cases for TCET; The challenge of meeting EU clinical data requirements; Guidance on preparing for the EU Artificial Intelligence Act; and Windham Capital's Sarah Fox on mastering market access challenges for digital health technologies.
